HIA was used in an article by the Vigour Times as an example of a group not satisfied with the Drug Enforcement Administration’s (DEA) announcement that healthcare providers will be permitted to continue using telemedicine to prescribe certain controlled substances until the end of 2024. HIA believes the DEA could have and should have done more.
However, the Health Innovation Alliance, a health technology advocacy group representing providers, insurers, patients, and others, criticized the DEA for unnecessarily delaying progress.
In a statement, the organization said, “While this extension will benefit millions of Americans who require vital medications, it is important to note that an extension is not a permanent solution. The DEA needs to stop stalling, acknowledge the success of tele-prescribing, and trust the medical professionals who are providing care to patients.”